The frequency of hepatotoxicity and myelotoxicity in leukemic children with different high doses of methotrexate
Background and objectives: Methotrexate (MTX) is a chemotherapeutic agent that functions as a folic acid antagonist. The frequency of high dose methotrexate (HDMTX)-associated toxicity is variable. In this study, we investigated the frequency of myelotoxicity and hepatotoxicity 7 days after HDMTX in...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-12-01
|
Series: | International Journal of Pediatrics and Adolescent Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352646716300588 |